In a year dominated by onshoring stories, Aragen has seized the advantages of running a biotech business in India.

Explore the latest news and expert commentary by Fiona Ford, brought to you by the Contributor of BioProcess International.

Explore the latest news and expert commentary by Melissa Nixon, brought to you by the Contributor of BioProcess International ...

The US Food and Drug Administration (FDA) announced the launch of a new framework to expedite therapies for ultra-rare diseases. The program will focus on targeted, individualized treatments for ...

AbbVie invests $380m in North Chicago for API manufacturing, creating 300 jobs, boosting US R&D, and expanding domestic ...

Swiss multinational pharmaceutical company Novartis announced that it will build a radioligand therapy (RLT) manufacturing facility in Denton, Texas. The facility will be 46,000 square feet, joining ...

According to the public release, Andelyn Biosciences and the Drake Rayden Foundation will work in partnership with Steven ...

The milestone is being celebrated as a “huge moment” for rare disease drug development.

Livestock vaccine demand surges but requires specialized animal-vaccine manufacturing workflows with distinct production ...

Platform-enabled vaccine design unlocks safer, more effective solutions with outer-membrane vesicles (OMVs) emerging as ...

AI tools promise to compress drug development timelines from decades to years, accelerating data analysis and testing for ...

Pharming uses living organisms as bioreactors for cheaper, sustainable drug production, but requires navigating complex IP ...